Latest Insider Transactions at Arena Pharmaceuticals Inc (ARNA)
This section provides a real-time view of insider transactions for Arena Pharmaceuticals Inc (ARNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ARENA PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ARENA PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 12
2021
|
Nawal Ouzren Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,488
+39.28%
|
-
|
|
Feb 02
2021
|
Robert Lisicki EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,500
-27.21%
|
$1,365,000
$78.52 P/Share
|
|
Feb 02
2021
|
Robert Lisicki EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+39.38%
|
$700,000
$40.95 P/Share
|
|
Jan 19
2021
|
Jayson Donald Alexander Dallas Director |
SELL
Open market or private sale
|
Direct |
1,327
-20.0%
|
$106,160
$80.5 P/Share
|
|
Jan 19
2021
|
Amit Munshi President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-86.58%
|
$4,000,000
$80.14 P/Share
|
|
Jan 19
2021
|
Amit Munshi President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+46.4%
|
$750,000
$15.5 P/Share
|
|
Jan 15
2021
|
Amit Munshi President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-54.39%
|
$4,000,000
$80.63 P/Share
|
|
Jan 15
2021
|
Amit Munshi President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+46.4%
|
$750,000
$15.5 P/Share
|
|
Jan 12
2021
|
Amit Munshi President and CEO |
SELL
Open market or private sale
|
Direct |
14,877
-28.72%
|
$1,100,898
$74.87 P/Share
|
|
Jan 07
2021
|
Amit Munshi President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,523
-27.36%
|
$656,271
$77.59 P/Share
|
|
Jan 07
2021
|
Amit Munshi President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,400
+42.9%
|
-
|
|
Jan 07
2021
|
Vincent Aurentz Executive VP and CBO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+40.0%
|
-
|
|
Jan 07
2021
|
Robert Lisicki EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,159
-25.07%
|
$243,243
$77.59 P/Share
|
|
Jan 07
2021
|
Robert Lisicki EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,600
+50.0%
|
-
|
|
Dec 11
2020
|
Jayson Donald Alexander Dallas Director |
BUY
Open market or private purchase
|
Direct |
5
+0.08%
|
$345
$69.31 P/Share
|
|
Dec 08
2020
|
Amit Munshi President and CEO |
SELL
Open market or private sale
|
Direct |
6,517
-45.68%
|
$456,190
$70.0 P/Share
|
|
Dec 08
2020
|
Jayson Donald Alexander Dallas Director |
BUY
Open market or private purchase
|
Direct |
5
+0.08%
|
$330
$66.25 P/Share
|
|
Dec 01
2020
|
Robert Lisicki EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,872
-64.12%
|
$251,680
$65.88 P/Share
|
|
Nov 25
2020
|
Amit Munshi President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,183
-26.65%
|
$336,895
$65.5 P/Share
|
|
Nov 25
2020
|
Amit Munshi President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+37.56%
|
-
|
|
Nov 25
2020
|
Vincent Aurentz Executive VP and CBO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+50.0%
|
-
|
|
Nov 25
2020
|
Christopher Cabell EVP, Head of R&D, and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,099
-43.96%
|
$71,435
$65.5 P/Share
|
|
Nov 25
2020
|
Christopher Cabell EVP, Head of R&D, and CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
-
|
|
Nov 25
2020
|
Robert Lisicki EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,428
-38.54%
|
$157,820
$65.5 P/Share
|
|
Nov 25
2020
|
Robert Lisicki EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,300
+50.0%
|
-
|